Lexeo Therapeutics, Inc. (LXEO)
(Delayed Data from NSDQ)
$12.64 USD
-0.37 (-2.84%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $12.62 -0.02 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Lexeo Therapeutics, Inc. [LXEO]
Reports for Purchase
Showing records 1 - 1 ( 1 total )
Company: Lexeo Therapeutics, Inc.
Industry: Medical - Drugs
Heart and CNS Gene Therapy; 2024 Catalyst Trifecta; Initiate at Buy and $22 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
|